Warning letterFDA · Aug 6, 2021
Blue Poppy Enterprises Inc MARCS-CMS 614126, August 06, 2021
Named company: Blue Poppy Enterprises Inc
A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, your Modified Perilla & Mentha, Empowered…
Lot information: not specified in this record.
